ICF in Takayasu Arteritis
Problem Analysis Based on the International Classification of Functioning, Disability and Health in Patients With Takayasu Arteritis
1 other identifier
interventional
15
1 country
1
Brief Summary
The aim was to analyze the problem in patients with Takayasu Arteritis based on the International Classification of Functioning, Disability and Health.The sample of our study will consist of individuals between the ages of 18-65 who have been diagnosed with Takayasu Arteritis by rheumatologists and are followed by Pamukkale University Rheumatology Clinic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2024
CompletedFirst Submitted
Initial submission to the registry
February 24, 2024
CompletedFirst Posted
Study publicly available on registry
March 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 25, 2024
CompletedMay 14, 2024
May 1, 2024
28 days
February 24, 2024
May 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
6 open-ended questions
ICF
25 minutes
Study Arms (1)
Experimental
EXPERIMENTALTakayasu Arteritis patients between the ages of 18-65
Interventions
Matching the answers given to the question set consisting of 6 open-ended questions with ICF
Eligibility Criteria
You may qualify if:
- Volunteering to participate in the study
- Being diagnosed with Takayasu Arteritis by a rheumatologist
You may not qualify if:
- Having cognitive impairment that makes it difficult to cooperate
- Being pregnant
- Having a neurological disease
- Having had any surgery in the last year
- Having another concurrent rheumatic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Elif Gur Kabul
Uşak, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 24, 2024
First Posted
March 4, 2024
Study Start
February 21, 2024
Primary Completion
March 20, 2024
Study Completion
March 25, 2024
Last Updated
May 14, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share